Bone remodeling involves the resorption of bone by osteoclasts and the synthesis of bone matrix by osteoblasts. Receptor activator of NF-kB ligand (RANKL, also known as ODF and OPGL), a member of the tumor necrosis factor (TNF) family, triggers osteoclastogenesis by forming a complex with its receptor, RANK. We have determined the crystal structure of the extracellular domain of mouse RANKL at 2.2-Å resolution. The structure reveals that the RANKL extracellular domain is trimeric, which was also shown by analytical ultracentrifugation, and each subunit has a ␤-strand jellyroll topology like the other members of the TNF family. A comparison of RANKL with TNF␤ and TNF-related apoptosis-inducing ligand (TRAIL), whose structures were determined to be in the complex form with their respective receptor, reveals conserved and specific features of RANKL in the TNF superfamily and suggests the presence of key residues of RANKL for receptor binding.
gand (OPGL), belonging to a member of the tumor necrosis factor (TNF) ligand family, is expressed on osteoblasts/stromal cells as a type-2 membrane protein in response to the stimulators of bone resorption (2) (3) (4) . RANKL induces osteoclastogenesis by sending signals to osteoclast progenitors. RANKL was first cloned as a regulatory factor of dendritic cells (5) and is also identical to TNF-related activation-induced cytokine (TRANCE), which was cloned as a regulatory factors of T cells (6) . RANK, a member of the TNF receptor (TNFR) family, was identified as a receptor for RANKL. The interaction between RANKL expressed by osteoblasts/stromal cells and RANK expressed on osteoclast precursors is essential for osteoclastogenesis (7) . Osteoprotegerin (OPG) (8) , also known as osteoclastogenesis inhibitory factor (OCIF) (9 -11) , is a secreted member of the TNFR family. OPG is a decoy receptor of RANKL and inhibits osteoclast maturation. RANKL, RANK, and OPG play critical roles in bone metabolism.
To date the three-dimensional structures of four ligands belonging to the TNF family have been determined; they are TNF␣ (12, 13) , TNF␤ (14) , CD40 ligand (CD40L) (15) , and TNF-related apoptosis-inducing ligand (TRAIL) (16, 17) . In addition, two ligand-receptor complex structures, TNF␤-TNF receptor 1 (TNFR1) (18) and TRAIL-death receptor 5 (DR5) (19 -21) were determined. Their crystal structures show that the ligand-receptor complex is composed of a homotrimer with three receptors, suggesting that the homotrimer induces the trimerization of the receptor, resulting in an induction of the transmembrane signaling.
In this report, we present the crystal structure of the extracellular domain of mouse RANKL. The structure was determined at 2.2-Å resolution by the multiple anomalous dispersion (MAD) method (22) . We also discuss conserved and specific features of RANKL in comparison with TNF␤ and TRAIL, which have been determined to be in a complex with their respective receptor. These features are likely to play critical roles in receptor binding.
EXPERIMENTAL PROCEDURES
Expression, Purification, and Crystallization-The soluble extracellular domain of mouse RANKL (residues 137-316) was overexpressed in Escherichia coli as a fusion protein with glutathione S-transferase using the vector pGEX-3X (Amersham Biosciences, Inc.). The fusion protein was purified by affinity purification with a glutathione column (Amersham Biosciences, Inc.) and digested with endoproteinase Arg-C (Takara). The digested RANKL (residues 157-316) was purified by ion-exchange column chromatography with a Mono S column (Amersham Biosciences, Inc.). The buffer was changed by gel filtration (Superdex-75, Amersham Biosciences, Inc.) to 25 mM Tris-HCl (pH 7.4), and the pooled protein was concentrated to 30 mg/ml with Centriprep-10 (Millipore). The N terminus of the digested RANKL was determined by Edman degradation. The selenomethionine (SeMet)-labeled RANKL was prepared by the inhibition of methionine biosynthesis method (23) and purified as the wild type with a buffer containing 10 mM dithiothreitol and 0.2 mM EDTA to prevent the oxidation of * The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
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selenium. The substitution ratio (ϳ100%) by SeMet was elucidated by amino acid analysis and mass spectrometry. Native crystals of RANKL were obtained at 295 K by hanging-drop vapor diffusion, equilibrated against a reservoir solution containing 14% (w/v) polyethylene glycol 8000, 30% (v/v) ethylene glycol, 300 mM NaCl, and 0.1 M HEPES (pH 7.5). Crystals of the SeMet-labeled RANKL were grown by the streak seeding method (24) using the native crystals as seeds against a reservoir solution containing 11% (w/v) polyethylene glycol 8000, 30% (v/v) ethylene glycol, 300 mM NaCl, and 0.1 M HEPES (pH 7.5). The crystals belong to the space group P2 1 2 1 2 1 with a ϭ 65.68 Å, b ϭ 78.98 Å, c ϭ 100.05 Å and contain one trimer (three subunits) in the asymmetric unit (V M ϭ 2.40 Å 3 /Da) (25) . Before data collection, the SeMet-labeled crystals were flash-cooled under a nitrogen stream at 120 K after adding a cryoprotectant solution containing 10% (v/v) glycerol and stored in liquid nitrogen.
Data Collection, Structure Determination, and Refinement-Data collection, phasing, and refinement statistics are summarized in Tables  I and II . X-ray data for MAD phasing (22) and refinement were collected from a single crystal at 100 K on BL-40B2 at SPring-8 (Hyogo, JAPAN) using an Raxis IV ϩϩ imaging-plate system. A four-wavelength experiment was performed, the absorption peak at 0.9800 Å, edge at 0.9803 Å, and two remote data at 1.000 and 0.9300 Å. The four data sets were processed with the DENZO and SCALEPACK programs (26) and scaled with the program SCALEIT in the CCP4 suite (27) . All of the nine selenium positions in the asymmetric unit were found by the program SHELXS-86 (28) using the peak data. The heavy-atom parameters were refined, and the initial phases were calculated with the program ML-PHARE (27) . The phases were modified with the program DM (27) by solvent flattening, histogram matching, and non-crystallographic symmetry averaging based on the selenium positions. The initial model was built with the program O (29) and refined with the program X-PLOR (30) against the peak data to 2.2-Å resolution. In the early stage of the refinement, the non-crystallographic symmetry restraints were introduced to all of the main-chain atoms among the three subunits. At the later stage of the refinement, the restraints for four loop regions were excluded, and a bulk solvent correction (31) was applied as guided by R-free (32) . Model geometry was checked using O and the program PROCHECK (33) . The solvent accessibility was calculated by the program GRASP (34) using a probe of 1.4-Å radius.
Analytical Ultracentrifugation-Sedimentation equilibrium experiments were performed on a Beckman XL-I analytical ultracentrifuge. Samples were loaded in double-sector cells with charcoal-filled Epon centerpieces with a column length of 4 mm and quartz windows. Conditions were 20 mM Na 2 HPO 4 (pH 6.8), 100 mM NaCl at 293 K. Equilibrium was defined by no change in the protein distribution spectra acquired 16 h apart. The partial specific volume was estimated to be 0.728 ml/g for the RANKL extracellular domain (residues 157-316), and the solvent density was estimated to be 1.007 ml/g. The data were analyzed with a single homogeneous species model.
RESULTS AND DISCUSSION
Oligomeric State-We measured the molecular weight of the RANKL extracellular domain (residues 157-316) by analytical ultracentrifugation in 20 mM Na 2 HPO 4 (pH 6.8), 100 mM NaCl. A sedimentation equilibrium data set is shown in Fig. 1 . The molecular mass determined from this analysis was 57.5 (Ϯ 0.7) kDa, and this with the monomer molecular mass predicted from the sequence (17.8 kDa) indicate that RANKL is trimeric. The trimeric state of RANKL is consistent with the other crystal structures of the TNF ligand superfamily.
Structure Determination-The extracellular domain of mouse RANKL (residues 157-316) was crystallized with the asymmetric unit containing three subunits, subunits A, B, and C, forming a trimer. Diffraction data were collected with synchrotron radiation at SPring-8, and the structure of the SeMetlabeled RANKL was solved by the MAD method. The initial electron density map was of excellent quality (Fig. 2) . The model was easily constructed and refined to 2.2-Å resolution with a crystallographic R factor of 22.6% and R-free of 27.4%. The final model of RANKL consists of three subunits (residues FIG. 1. Sedimentation equilibrium data for the extracellular domain of mouse RANKL. Lower, absorbance at 280 nm versus radial position. Data points are shown with the best-fit curve for a singlespecies model. Best-fit weight-average molecular mass is M r ϭ 57.5 (Ϯ 0.7) kDa and indicates that the extracellular domain of mouse RANKL is trimeric. Upper, the distribution of residuals for the fit of the primary data (absorbance at 280 nm versus radius) to a model for a single species is shown. Conditions: 20 mM Na 2 HPO 4 (pH 6.8), 100 mM NaCl, 293 K, and 20,000 rpm.
FIG. 2. Typical electron density.
A, part of the electron density map calculated using phases based on MAD followed by density modification at 2.5-Å resolution. B, part of the A-weighted (2F o Ϫ F c ) electron density map phased using the final model at 2.2-Å resolution. The two maps are contoured at 1.6, respectively. The mean phase error and map correlation coefficient after MAD phasing followed by density modification were 39.2°and 0.89, respectively, to those calculated using the final model at 2.5-Å resolution.
161-316) and 69 water molecules. The model of the four amino acid residues at the N terminus was not constructed because there was no electron density. The model has good geometry, and all residues have allowed main-chain torsion angles. Data collection, phasing, and refinement statistics are summarized in Tables I and II . The electron density of residues 171-177, 224 -234, 245-250, and 266 -268 of the B subunit and residues 171-179, 246 -250, and 265-268 of the C subunit was not clearly visible presumably because of high flexibility.
Overall Structure-Like the other members of the TNF ligand family, the RANKL subunit has a ␤-strand jellyroll topology (Fig. 3A) . The RANKL monomer is composed of two ␤-sheets; they are the ␤-strands AЈЈ A, H, C, and F, which form the inner ␤-sheet and are involved in the intersubunit contacts, and ␤-strands BЈ, B, G, D, and E, which form the outer ␤-sheet. Despite the low sequence identity, the overall structure of RANKL is similar to that of the other TNF family members (Fig. 3B) . The extracellular domain of RANKL has 23% sequence identity with TNF␤ and 33% with TRAIL (Fig. 4A) . In comparing of the structure of RANKL with that of TNF␤ (PDB code 1TNR (18)) and TRAIL (PDB code 1DV4 (20) ) in the complex form with their respective receptor, the root mean square deviations of RANKL is 1.17 Å with TNF␤ (126 equivalent C␣ atoms) and 1.27 Å with TRAIL (131 equivalent C␣ atoms). The trimeric interface consists of a 7,440-Å 2 area (2,480 Å 2 /subunit) and has a highly hydrophobic character with a high proportion of aromatic residues (Fig. 4A) . The trimeric interface is well conserved in the TNF family, whereas the conformations of the surface loops are extremely variable (Fig. 3B) . The loops that have large differences are the AAЈЈ loop, linking the ␤-strands of A and AЈЈ and, likewise, the DE loop and EF loop. The electron densities of the DE and EF loops in two of the three subunits are poor, suggesting that the two loops are highly flexible. The DE and EF loops in the third subunit are well ordered, presumably because of crystal packing. The largest difference in the sequence alignment is the length of the AAЈЈ loop; that of RANKL is seven residues longer than that of TNF␤ and nine residues shorter than that of TRAIL (Fig. 4A) . The AAЈЈ loop is likely to have a critical role in receptor binding as discussed below.
Receptor Binding Site-The binding of RANKL to its receptor RANK and decoy receptor OPG is expected to be similar to that of the TNF␤-TNFR1 and TRAIL-DR5 complexes because the overall fold of RANKL is similar to that of the TNF family. Furthermore, RANK and OPG belong to the TNFR family. The two crystal structures of the TNF␤-TNFR1 and TRAIL-DR5 complexes show that the receptor binds the ligand diagonally along the crevices of the ligand subunit-subunit interface (Fig.  5A) (18 -21) . Residues of the ligands that are involved in receptor binding are in the AAЈЈ loop, the C-terminal region of the C strand, the N terminus of the D strand, the DE loop, the N terminus of the F strand, and the GH loop (Fig. 4A) . Members of the TNFR family are characterized by extracellular repeats containing three disulfide bridges with a cysteine-knot topology. The number of repeats TNFR1 has is four, DR5 has three, and RANK and OPG have four cysteine-rich domains (CRD). Among the repeats, the second and third CRDs (CRD2 and CRD3) are known to be important for ligand binding (Fig. 5B) . Furthermore, the extensive mutagenesis studies on the ligands TNF␣, TNF␤, and TRAIL allow us to predict residues, which play a critical role in the binding of RANKL to the receptors. We propose three residues in RANKL that are likely to be important for the ligand-receptor interaction. The three residues of mouse RANKL are Ile-248 in the DE loop for a conserved interaction, Gln-236 in the N-terminal region of the D strand, and Lys-180 in the AAЈЈ loop for the specific interaction. All of these three residues are conserved in human RANKL. In addition to the ligand, two loops in the receptors of RANK and OPG can also be considered important for ligand interaction. They are the loop in the CRD2 for the conserved interaction and the loop in the CRD3 for the specific interaction.
Although the charge distribution on the surface of mouse RANKL, TNF␤, and TRAIL are very different, the DE loop region of mouse RANKL has a hydrophobic character as seen in TNF␤ and TRAIL (Fig. 6) . The loop regions of TNF␤ and TRAIL bind their respective receptor mainly through hydrophobic interactions, suggesting that RANKL also interacts with OPG and RANK in the same manner. Mutagenesis studies show that Tyr-108 in TNF␤ and Tyr-216 in TRAIL are critical for receptor binding (17, 35) . In the ligand-receptor complex structures, Tyr-108 in the DE loop of TNF␤ directly interacts with residues of the receptor, and Tyr-216 in TRAIL also interacts with residues in the hydrophobic groove of the receptor surface in CDR2. Both mouse RANKL and human RANKL have a hydrophobic residue, Ile (Ile-248 in mouse RANKL and Ile-249 in human RANKL), at an equivalent position to Tyr-108 in TNF␤ and Tyr-216 in TRAIL. Despite its hydrophobic character, the DE loop is exposed to the solvent. In the mouse RANKL crystal, two of the three DE loops in the asymmetric unit are disordered, and only the electron density of the other DE loop is clearly visible. This is probably due to crystal packing. Therefore, the DE loop appears to be flexible in the free state and is likely to bind with the receptor through hydrophobic interactions becoming ordered in the complex form.
Another critical residue of mouse RANKL for receptor binding is expected to be Gln-236 (Gln-237 in human RANKL), which lies in the N-terminal region of the D strand. Gln-205 in TRAIL forms hydrogen bonds to the backbone of Glu-151 and Met-152 of DR5 in the TRAIL-DR5 complex (19 -21) . Mutating Gln-205 in TRAIL to Ala decreases its binding activity (17) . In contrast, TNF␤ has a tyrosine residue (Tyr-96) at this position that binds to TNFR1 through van der Waals interaction. The residues of RANK and OPG equivalent to Glu-151 and Met-152 of DR5 are also acidic and hydrophobic, respectively (Glu-126 and Cys-127 in mouse RANK, Glu-125 and Cys-126 in human RANK, Glu-116 and Phe-117 in mouse OPG and human OPG, respectively) (Fig. 4B) . Gln-236 of mouse RANKL may form hydrogen bonds to RANK and OPG in the same manner as that of the TRAIL-DR5 complex.
As described above, the most dramatic difference among the three ligands is the length of the AAЈЈ loop. Arg-149 of TRAIL in the AAЈЈ loop, which has the longest insertion, makes a salt bridge to Glu-147 in DR5 (19 -21) , whereas the shorter AAЈЈ loop of TNF␤ has no such interaction in the TNF␤-TNFR1 complex (Fig. 5B) . The deletion mutant of TRAIL, which lacks the AAЈЈ loop, completely abolished the binding activity (20, 21) . The residue in RANKL, at a similar position to Arg-149 of TRAIL, is a lysine residue (Lys-180 of mouse RANKL and Lys-181 of human RANKL). Furthermore, residues at a similar position to Glu-147 of DR5 are Asp-124 in mouse RANK, Asp-123 in human RANK, and Glu-114 in mouse OPG and human OPG. Superposition of mouse RANKL with TNF␤ in complex with TNFR1 shows that Lys-180 in the long AAЈЈ loop is able to form a possible interaction with the receptor, presumably through a salt bridge with Asp in RANK and Glu in OPG (Fig.  5C ). In TRAIL, there were alterations in the conformation of several surface loops that appear to be a consequence of receptor binding. Among those loops, the AAЈЈ loop is disordered in the free TRAIL structure but is ordered in the complex structure (20, 21) . In the mouse RANKL crystal, the N-terminal regions of the two AAЈЈ loops in the asymmetric unit are also disordered. Thus, the AAЈЈ loop of mouse RANKL is also likely to undergo a conformational change upon receptor binding. Further structural studies on the complex form between RANKL and the receptors and mutagenesis studies of the above residues are necessary to confirm this possibility.
In summary, we have determined the three-dimensional 
FIG. 4. Sequence alignments for the TNF and TNF receptor families.
A, alignment is carried out based on the three-dimensional structures for mouse RANKL (mRANKL), TNF␤, and TRAIL and manually for human RANKL (hRANKL). Secondary structure assignments and dots above the sequence at every tenth residue are for mRANKL. Conserved residues in the TNF ligand family are shown in bold. Aromatic residues in the subunit interface of mRANKL and the corresponding residues of hRANKL are colored in blue. B, alignment is carried out based on the three-dimensional structures for TNFR1 and DR5 and manually for mouse RANK (mRANK), human RANK (hRANK), mouse OPG (mOPG), and human OPG (hOPG). Residues involved in ligand-receptor interactions in the TNF␤-TNFR1 and TRAIL-DR5 complexes are shaded. Residue numbers are shown to the left of the sequences. Key residues important for receptor binding and discussed in the text are colored in red.
structure of the extracellular domain of mouse RANKL at 2.2-Å resolution by x-ray crystallography and predicted the key residues that are likely to interact with the receptors RANK and OPG. The crystal structure can help to further understand the ligand-receptor interaction of the TNF/TNFR family and provides a tool to develop drug candidates that inhibit osteoclastogenesis and mediate diseases of bone metabolism.
